GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Zim Laboratories Ltd

Zim Laboratories Ltd schedules Q4 & FY26 Earnings Conference Call

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 13 May 2026, 08:24 PM IST  ·  BSE ID: 50653403-c2c8-435b-9b54-2796ba4b9fe0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company will discuss its latest quarterly and full-year financial results in a conference call on May 20, 2026.
🤖 AI Summary
  • Zim Laboratories Ltd will hold its Q4 and FY26 Earnings Conference Call on May 20, 2026.
  • The conference call is scheduled to commence at 12:00 p.m. IST.
  • Dr. Anwar Siraj Daud, Chairman and Managing Director, will participate from the company.
  • Mr. Shyam Mohan Patro, Chief Financial Officer, will also be on the call.
  • Go India Advisors is confirmed as the host for the earnings conference call.
👥 What This Means For Shareholders
✅
Action Required
Shareholders interested in the company's financial performance may participate in the conference call on May 20, 2026.
👤
Who Is Affected
All shareholders have access to this information and the opportunity to listen to the management discussion on Q4 and FY26 financial results.
🔍
Management Signal
Management is providing a platform for direct communication and transparency regarding the company's latest financial performance to the public.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q4 & FY26 financial results disclosure filing — check actual numbers
Earnings call transcript — review detailed management commentary
Investor presentation, if any, post-call — assess strategic updates
LOW RISK This filing is a routine notification of an earnings call and carries no inherent risk.
💡 Investor Takeaway
Zim Laboratories Ltd has scheduled its Q4 and FY26 earnings conference call for May 20, 2026, at 12:00 p.m. IST. This call will include participation from the Chairman and MD, Dr. Anwar Siraj Daud, and CFO, Mr. Shyam Mohan Patro, to discuss the financial results.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.